REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 32 filers reported holding REPROS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allegis Investment Advisors, LLC | 342,709 | $569,000 | 0.29% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $638,000 | 0.07% |
| Alambic Investment Management, L.P. | 69,191 | $111,000 | 0.03% |
| Acrospire Investment Management LLC | 15,119 | $24,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,486 | $158,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 315,030 | $507,000 | 0.01% |
| SIMPLEX TRADING, LLC | 86,054 | $138,000 | 0.01% |
| A.R.T. Advisors, LLC | 34,315 | $55,000 | 0.00% |
| Mariner Wealth Advisors-Cincinnati, LLC | 11,000 | $18,000 | 0.00% |
| Renaissance Technologies | 561,713 | $904,000 | 0.00% |